Client Extranet
|
Site Map
|
RSS
About Us
Practices
People
Offices
News & Insights
Careers
Blogger
Delicious
Digg
Facebook
LinkedIn
Twitter
Email
Home
»
People
»
Daniel F Donovan III
» Publications
Daniel F Donovan III (Dan)
Partner
WASHINGTON, D.C.
T: +1 202 661 7815
F: +1 202 626 3737
E-mail
CLOSE
[x]
All Offices
Abu Dhabi
Atlanta
Austin
Charlotte
Dubai
Frankfurt
Geneva
Houston
London
Moscow
New York
Paris
Riyadh
San Francisco
Silicon Valley
Singapore
Washington, D.C.
All Practices
Antitrust
Antitrust & IP
Antitrust Counseling
Antitrust Energy
Cartel Litigation
Civil Antitrust Litigation
EU Competition
Healthcare Antitrust
M&A / Joint Ventures
Pharma Antitrust Solutions
UK Competition and Regulatory
Appellate Litigation
Asian Practice
Asset Management
Bankruptcy/Restructuring
Climate Change
Commercial Disputes
Congressional Investigations
Construction and Procurement
Construction Litigation
Consumer Class Action
Copyright
Corporate Espionage & Competitive Intelligence
Corporate Finance
Corporate Governance
Corporate Plaintiffs Litigation
D&O Liability Litigation
Domestic Arbitration/ADR
E-Commerce
E-Discovery
Emerging Growth
Employee Benefits & Executive Compensation
Energy & Natural Resources
Arbitration
Construction and Procurement
Construction Dispute Resolution
Environmental Litigation
Finance
Financial Restructuring
Foreign Corrupt Practices Act
Intellectual Property
LNG
Maritime
Mergers and Acquisitions
Mining and Natural Resources
Nuclear
Oil & Gas
Oil & Gas Exploration and Production
Oil & Gas Litigation
Oil & Gas Midstream and Pipelines
Oil & Gas Oil Field Services
Oil & Gas Refining
Petrochemical
Power
Power Litigation
Private Equity
Project Development
Regulatory
Renewable/Alternative Energy
Tax
Tort Litigation
Environmental
Environmental Litigation
ERISA & Employee Benefits Litigation
FDA & Life Sciences
Financial Markets
Distressed Assets
Financial Markets Policy
Subprime and Capital Markets
Financial Services
Financial Services Litigation
First Amendment/Defamation
Franchise & Distribution
Franchise & Distribution Litigation
German Practice
Government Advocacy & Public Policy
Political Law
Healthcare Industry
Academic Medical Centers
Antitrust
Children’s Health
Civil Litigation
Class Actions
Clinical Research Compliance
Financial Restructuring
Government Advocacy/Public Policy
Government Investigations/FCA
Health Information Privacy & Security
Healthcare M&A
Healthcare Reform Task Force
Information Technology/EHRs
International Healthcare
Labor & Employment
Managed Care, Health Plans and Insurers
Private Equity
Provider Representation
RAC & MIC Audits and Appeals
Regulatory and Compliance
Reimbursement
Tax
Tax Exempt Bond Financings
Healthcare Litigation
Homeland Security
Infrastructure Finance
Insurance Coverage and Recovery
Intellectual Property
International
International Arbitration
International Trade/WTO
Islamic Finance
Arbitration
Asset Finance
Energy
Healthcare
Middle East & North Africa
Petrochemicals and Refining
Power and Water
Private Equity
Private Equity/Investment Funds
Project Finance
Projects and Construction
Real Estate
Saudi Arabia Practice
Joint Ventures / Strategic Alliances
Labor & Employment
Latin America Practice
Licensing
Marketing & Advertising Litigation
Mass Tort
Mergers & Acquisitions
Our Approach to Litigation
Outsourcing
Patents
Pharma/Biotech/Med Devices
Antitrust
Business Litigation
Corporate
Emerging Companies
Government Advocacy
Government Investigations
Intellectual Property
International Arbitration
Labor & Employment
Products Liability/Mass Tort
Privacy & Information Security
Private Equity/Investment Funds
Private Finance
Product Liability Litigation
Professional Liability Litigation
Project & Equipment Finance
Public Finance
Real Estate
Russia Practice
Securities Litigation/D&O Liability
Special Matters/Government Investigations
Sports, Media & Entertainment
Tax
Tax Litigation
Tax-Exempt
Technology Transactions
Telecommunications
Toxic Tort Litigation
Trade Secrets & Non-Compete Litigation
Trademarks/False Advertising
Advanced Search
Profile
|
Matters
|
News & Insights
PUBLICATIONS
Go to Page
13 Oct 2011
CLIENT ALERT
Congressional Investigation Targets Food Service Contractors and “Wide Spread Waste”
01 Oct 2011
NEWSLETTER
Energy Newsletter - October 2011
21 Sep 2011
CLIENT ALERT
Congressional Investigation of Solyndra, Inc. and Department of Energy Loan Programs Office
07 Sep 2011
CLIENT ALERT
HHS Final Rule Regarding Investigator Financial Interests
31 Jan 2011
NEWSLETTER
Health Headlines
31 Jan 2011
CLIENT ALERT
HHS OIG Recommends New Federal Regulations to Govern NIH Grantee Institutions
27 Apr 2010
CLIENT ALERT
Council of Medical Specialty Societies Issues Code for Interactions with the Life Sciences Industry
31 Mar 2010
CLIENT ALERT
Regarding Proposed Rule on DTC Broadcast Drug Ads
08 Mar 2010
CLIENT ALERT
GAO Report Could Lead to Increased Criminal Prosecutions for Executives
25 Feb 2010
CLIENT ALERT
Senator Grassley Probes Ties Between WebMD and Industry
06 Nov 2009
CLIENT ALERT
FDA Holds Second Transparency Task Force Public Meeting
01 Jul 2009
ARTICLE
|
The Metropolitan Corporate Counsel
FDA's New Transparency Task Force: Mission And Opportunity For Public Comment
22 Jun 2009
CLIENT ALERT
Subcommittee on Health Examines Medical Device Safety
12 Jun 2009
CLIENT ALERT
FDA’s New Transparency Task Force: Mission and Opportunity for Public Comment
17 Feb 2009
CLIENT ALERT
Federal Contracting to Receive Enhanced Government Scrutiny in 2009
28 Jan 2009
CLIENT ALERT
Grassley, Kohl Introduce Physician Payments Disclosure Law
19 Nov 2008
CLIENT ALERT
Potential False Claims Act Liability for Federal “Bailout” Participants
14 Oct 2008
CLIENT ALERT
House Financial Crisis Hearings Probe Lehman Brothers and AIG; Signal Legislative Reforms
06 Oct 2008
CLIENT ALERT
Financial Crisis Oversight Hearings Scheduled Before House Oversight and Government Reform Committee
03 Sep 2008
CLIENT ALERT
Congress and the President Appoint Members to Commission on Wartime Contracting
Go to Page
PRACTICE AREAS
Congressional Investigations
Financial Markets
Government Advocacy &
Public Policy
Healthcare Industry
Health Government Advocacy
Health Govt Investigations
Pharma/Biotech/Med Devices
Pharma Government Advocacy & Public Policy
Pharma Government Investigations
EDUCATION
J.D., American University
B.A., University of Rochester
ADMISSIONS
Maryland
Washington, D.C.
